1. 219921-94-5
2. Repaglinide Related Compound A
3. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetyl-l-glutamate
4. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine, N-acetyl-glutamate Salt
5. 1u5q8kd140
6. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate Salt
7. (2s)-2-acetamidopentanedioic Acid;(1s)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine
8. (1s)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine N-acetyl-l-glutamate
9. 3-methyl-1-(2-piperidinophenyl)-1-butylamine, (s)-, N-acetyl-l-glutamate
10. (1s)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine; (2s)-2-acetamidopentanedioic Acid
11. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate
12. Mfcd09840998
13. Unii-1u5q8kd140
14. Dtxsid50176421
15. Bcp04251
16. Repaglinide Related Compound A [usp]
17. (s)-3-methyl-1-[2-(1-piperidinyl)phenyl]butylamine N-acetyl-l-glutamate Salt
18. Akos015919997
19. Ds-1077
20. (2s)-2-acetamidopentanedioic Acid,(1s)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine
21. Ac-23929
22. Repaglinide Related Compound A Rs [usp]
23. A25000
24. Ec 606-883-4
25. O10220
26. Repaglinide Related Compound A [usp-rs]
27. J-014399
28. Q27252888
29. Repaglinide Related Compound A [usp Impurity]
30. (s)-3-methyl-1-(2-piperidinophenyl)butylaminen-acetyl-l-glutamate
31. 3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate Salt
32. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine N-acetyl-glutamate Salt
33. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine,n-acetyl-glutamate Salt
34. N-acetyl-l-glutamate(s)-3-methyl-1-(2-piperidinophenyl)-1-butylamine
35. (2s)-2-acetamidopentanedioic Acid; (1s)-3-methyl-1-[2-(1-piperidyl)phenyl]butan-1-amine
36. (s)-3-methyl-1-(2-piperidine-1-phenyl)butylamine Compound With N-acetyl-l-glutamic Acid
37. L-glutamic Acid, N-acetyl-, Compd. With (.alpha.s)-.alpha.-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine (1:1)
38. L-glutamic Acid, N-acetyl-, Compd. With (alphas)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine (1:1)
| Molecular Weight | 435.6 g/mol |
|---|---|
| Molecular Formula | C23H37N3O5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 9 |
| Exact Mass | 435.27332129 g/mol |
| Monoisotopic Mass | 435.27332129 g/mol |
| Topological Polar Surface Area | 133 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 458 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
BUILDING BLOCK
SUPPLIERS
(S)-3-methyl-1-(2-piperidinyl)phenyl-butyl amine.N...
CAS Number : 219921-94-5
End Use API :
End Use API : Ibrutinib
About the Company : Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, Anqing City, Anhui Province---a famous historical and cultural city in China, ad...
(S, S')-3-METHYL-1-(2-PIPERIDINOPHENYL) BUTYLAMINE...
CAS Number : 219921-94-5
End Use API :
End Use API : Repaglinide
About the Company : SAINTSUN PHARMA, we are engaging mainly in the manufacturing and distributing APIs, Pharmaceutical Intermediates, Chemicals, Formulations, Medical supplies, etc... With a self-owned bra...
(S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine ...
CAS Number : 219921-94-5
End Use API :
End Use API : Repaglinide
About the Company : Established in 2000, Shodhana Laboratories offers a wide range of APIs and intermediates and caters to the generic and custom requirements of some of the most prestigious pharma compani...
END USE APIs
Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.
Minakem is manufacturing small molecules APIs including corticosteroids
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Robust product portfolio of APIs & capable of handling novel, complex and critical reactions.
RELATED INTERMEDIATES
